NovaBay Pharmaceuticals (NBY) Posts Q1 Loss of 8c/Share
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Provision for income taxes: 0
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Provision for income taxes: 0
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
NovaBay Pharmaceuticals (NYSE: NBY) reported Q1 EPS of ($0.08), $0.03 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $188 thousand versus the consensus estimate of $490 thousand.
For earnings history and earnings-related data on NovaBay Pharmaceuticals (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Kodiak Sciences Inc. (KOD) Misses Q2 EPS by 7c
- Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
